Abstract
Clonidine, 2-(2, 6-dichlorophenylamino)-2-imidazoline, referred to as St 155, Catapresan, Catapres or Catapressan, was the first antihypertensive agent known to act on the central nervous system. Its therapeutic value as an agent for controlling high blood pressure has been well established in recent years and its clinical use is growing.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aars, H.: Effects of Clonidine on aortic diameter and aortic baroreceptor activity. Europ. J. Pharmacol. 20, 52–59 (1972).
Alexandre, J.-M., Chevtllard, C., Menard, J., Schmitt, H.: Rôle des récepteurs α-adrén-ergiques dans la sécrétion de rénine du rat. J. Pharmacol. (Paris) 4 412–413 (1973).
Andén, N.E., Corrodi, H., Fuxe, K., Hökfelt, B., Hökfelt, T., Rydin, K., Svensson, T.: Evidence for a central noradrenaline receptor stimulation by Clonidine. Life Sci. 9, 513–523 (1970).
Andén, N.E., Grabowska, M., Strömbom, W.: Different alphα-adrenoceptors in the central nervous system mediating biochemical and functional effects of Clonidine and receptor blocking agents. Arch. Pharmacol. 292, 43–52 (1976).
Andén, N.E., Strömbom, U., Svensson, T.H.: Dopamine and noradrenaline receptor stimulation: reversal of reserpine induced suppression of motor activity. Psychopharmacologia (Berl.) 29, 289–298 (1973).
Anderson, C, Stone, T. W.: The effect on Clonidine on single cortical and medullary neurons Brit. J. Pharmacol. 49, 176–177P (1973a).
Anderson, C, Stone, T. W.: On the mechanism of action of Clonidine: effects on single central neurones. Brit. J. Pharmacol. 51, 259–365 (1973b).
Antonaccio, M.J.: Reflex responses to vertical tilting in dogs: a comparison with bilateral carotid occlusion. Pharmacologist 13, 192 (1971).
Antonaccio, M. J.: The effect of Clonidine (St 155) on adrenergic nerve function in intact and vagotomized animals. Fifth International Congress on Pharmacology, Abstracts of volunteer papers, 8, 44 (1972).
Antonaccio, M. J., Haley, J.: Studies on the mechanism and brain stem site of action of the hypotensive, bradycardic and reflex-enhancing actions of Clonidine in cats. Fed. Proc. 35, 323 (no. 655) (1976).
Antonaccio, M. J., Halley, J., Kerwin, L.: Functional significance of α-stimulation and α-blockade on responses to cardiac nerve stimulation in anesthetized dogs. Life Sci. 15, 765–777 (1974).
Antonaccio, M. J., Robson, R.D.: The effect of Clonidine on adrenergic nerve function in vagotomized and non vagotomized animals. J. Pharmacol, exp. Ther. 184, 631–640 (1973).
Antonaccio, M. J., Robson, R.D., Burrell, R.: Effects of Clonidine on baroreceptor function in anesthetized dogs. Europ. J. Pharmacol. 30, 6–14 (1975).
Antonaccio, M. J., Robsqn, R. D., Kerwin, L.: Evidence for increased vagal tone and enhancement of baroreceptor reflex activity after xylazine, (2-(2, 6-dimethylphenylamino)-4H-5, 6 dihydro-1, 3 thiazine) in anesthetized dogs. Europ. J. Pharmacol. 23, 311–315 (1973).
Armstrong, J. M., Boura, A.L.A.: Effects of Clonidine and guanethidine on peripheral sympathetic nerve function in the pithed rat. Brit. J. Pharmacol. 47, 850–852 (1973)
Audigier, Y., Virion, A., Schwartz, J. Ch.: Stimulation of cerebral histamine H2-receptors by Clonidine. Nature (Lond.) 262, 307–308 (1976).
Autret, A., Minz, M., Bellevaire, T., Cachera, H.P., Schmitt, H.: The REM sleep suppressing effect of a adrenostimulation in human C.N.S. Europ. J. of Clin. Pharmacol, (in press).
Autret, A.M., Schmitt, H., Fénard, S., Petillot, N.: Comparison of haemodynamic effects of α-sympathomimetic drugs. Europ. J. Pharmacol. 13, 208–217 (1971).
Baer, L., Brunner, H.R., Bard, R., Laragh, J.H.: Suppression of renin and aldosterone by Clonidine. Ann. intern. Med. 74, 830 (1971).
Baker, R.G., Anderson, E.G.: The antagonism of the effects of L-3–4-dihydroxy-phenylalanine on spinal reflexes by adrenergic blocking agents. J. Pharmacol, exp. Ther. 173, 224–231 (1970).
Barac, G.: Effect immédiat de la 2-(2, 6-dichlorophénylamino)-2-imidazoline (St 155) sur la diurèse et le débit sanguin rénal chez le chien. CR. Soc. Biol. (Paris) 164, 2406–2409 (1971).
Barnett, A.J., Cantor, S.: Observations on the hypotensive action of Catapres (Stl55) in man. Med. J. Aust. 1, 87–91 (1968).
Bartmus, D., Gumulka, S.W., Dinnendahl, V., Schonhofer, P.S.: Brain cyclic nucleotides and adrenolytics: effects on amphetamine and apomorphine induced changes. Arch. Pharmacol. 294 (Suppl.) R 11 (1976).
Baum, P.: Experimentelle Untersuchungen zur Nieren-Hämodynamik und zum Verhalten der Elektrolyte nach einmaliger Verabreichung von 2-(2, 6-Dichlorophenylamino)-2-Imidazo-lin-hydrochlorid. Arzneimittel-Forsch. 16, 1162–1165 (1966).
Baum, T., Eckfeld, D.K., Metz, N., Dinish, J.L., Rowles, G., Van Pelt, R., Shropshere, A. J., Fernandez, S.P., Gluckman, M.L, Bruce, N.F.: 2, 6-Dichlorobenzylidene amino-guanidine acetate (W-8678) a new hypotensive agent. Experientia (Basel) 25, 1066–1067 (1969).
Baum, T., Shropshire, A.T.: Inhibition of spontaneous sympathetic nerve activity by the antihypertensive agent, Wy-8678. Neuropharmacology 9, 503–506 (1970).
Baum, T., Shropshlre, A.T.: Studies on the centrally mediated hypotensive action of guanabenz. Europ. J. Pharmacol. 37, 31–44 (1976).
Baum, T., Shropshlre, A.T., Rowles, G., van Pelt, R., Fernandez, S. P., Eckfeld, D.K., Gluckman, M.I.: General pharmacologic actions of the antihypertensive agent 2–6 dich-robenzylidene aminoguanidine acetate (Wy 8678). J. Pharmacol, exp. Ther. 171, 276–287 (1970).
Beauvallet, M., Giudicelli, R., Chabrier, P., Najer, H.: Sur l’action vasculaire de quelques amino 2-oxazolines N-substituées. J. Physiol. (Paris) 51, 397–398 (1959).
Beck, L.: Active reflex vasodilatation in the innervated hind limb of the dog. Amer. J. Physiol. 201, 123–128 (1961).
Bentley, G. A., Li, D.M.F.: Studies on the new hypotensive drug St 155. Europ. J. Pharmacol. 4, 124–134 (1968).
Bloch, R., Bousquet, P., Feldman, J., Velly, J., Schwartz, J.: Action hypotensive de la Clonidine appliquée sur la surface ventrale du bulbe rachidien: analogie avec la dopamine. Thérapie 29, 251–259 (1974).
Blumberg, J.B., Taylor, R. E., Sulser, F.: Blockade by pimozide of a noradrenaline sensitive adenylate cyclase in the limbic forebrain: possible role of limbic noradrenergic mechanisms in the mode of action of antipsychotics. J. Pharm. Pharmacol. 27, 125–128 (1975).
Bock, J. U., Van Zwieten, P. A.: Central hyperglycaemic action of Clonidine. Arch. Pharmakol. 270, Suppl., R 11 (1971a).
Bock, J. U., Van Zwieten, P. A.: The central hyperglycaemic effect of Clonidine. Europ. J. Pharmacol. 16, 303–310 (1971b).
Bock, K.D., Heimsoth, V., Merguet, P., Schönermark, J.: Klinische und klinisch-experimentelle Untersuchungen mit einer neuen blutdrucksenkenden Substanz: Dichlorophenyl-aminoimidazolin. Dtsch. med. Wschr. 91, 1761–1770 (1966).
Bock, K.D., Merguet, P., Brandt, T., Murata, T.: Experimental studies with Clonidine hydrochloride in normotensive and hypertensive subjects. In: Conolly, M.E. (Ed.): Catapres in hypertension, pp. 101–112. London: Butterworths 1970.
Bock, K.D., Merguet, P., Murata, T., Heimsoth, V.: Klinisch-experimentelle Untersuchungen über die Wirkungen von Dichlorophenylaminoimidazolin. In: Hedlmeyer, Holtmeier, Pfeiffer (Eds.): Hochdrucktherapie, pp. 28–38. Stuttgart: Thieme 1968.
Bogaievsky, D., BoGaievsky, Y., Tsoucaris-Kupfer, D., ScHmitt, H.: Blockade of the central hypotensive effect of Clonidine by a adrenoceptor antagonists in rats, rabbits and dogs. Clin. exp. Physiol. Pharmacol. 1, 527–534 (1974).
Boissier, J.-R., Giudicelli, J.-F., Fichelle, J., Schmitt, T. Schmitt, Helene: Cardiovascular effects of 2-(2, 6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155). I. Peripheral sympathetic system. Europ. J. Pharmacol. 2, 333–339 (1968).
Boissier, J.-R., Giudicelli, J.-F., Larno, S., Fichelle, J.: Action du St 155 sur la sécrétion gastrique et l’ulcère expérimental. J. Pharmacol. (Paris) 1, 109–122 (1970).
Bolme, P., Corrodi, H., Fuxe, K., Hökfelt, T., Lidbrink, P., Goldstein, M.: Possible involvement of central adrenaline neurons in vasomotor and respiratory control. Studies with Clonidine and its interactions with piperoxane and yohimbine. Europ. J. Pharmacol. 28, 89–94 (1974).
Bolme, P., Corrodi, H., Fuxe, K.: Possible mechanism of the hypotensive action of 2, 6-dichlorobenzylidene aminoguanidine: evidence for central noradrenaline stimulation. Europ. J. Pharmacol. 23, 175–182 (1973).
Bolme, P., Forsyth, R.P., Ishizaki, T., Melmon, K.L.: Hemodynamic effects of systemic and central administration of Clonidine in the monkey. Amer. J. Physiol. 228, 1276–1279 (1975).
Bolmej, P., Fuxe, K.: Pharmacological studies on the hypotensive effects of Clonidine. Europ. J. Pharmacol. 13, 168–174 (1971).
Bolme, P., Fttxe, K.: Pharmacological studies on a possible role of central noradrenaline neurons in respiratory control. J. Pharm. Pharmacol. 25, 351–352 (1973).
Bousquet, P., Feldman, J., Velly, J., Belhadj-Mostefa, H., Bloch, R., Schwartz, J.: Rôle de la surface ventrale du bulbe rachidien dans la régulation de la pression artérielle et dans l’action hypotensive de la Clonidine. C R. Soc. Biol. (Paris) 169, 1359–1365 (1975a).
Bousquet, P., Feldman, J., Velly, J., Bloch, R.: Role of the ventral surface of the brain stem in the hypotensive action of Clonidine: Europ. J. Pharmacol. 34, 151–156 (1975b).
Bousquet, F., Guertzenstein, P.G.: Localization of the central cardiovascular action of Clonidine. Brit. J. Pharmacol. 49, 573–579 (1973).
Braestrup, C.: Effects of phenoxybenzamine, aceperone and Clonidine on the level of 3-methoxy-4-hydroxy phenylglycol (MOPEG) in rat brain. J. Pharm. Pharmacol. 26, 139–141 (1974).
Bralet, J., Rochette, L.: Influence du traitement par la Clonidine sur la synthèse des catecholamines dans le coeur, les glandes sous-maxillaires et la surrénale du rat. Biochem. Pharmacol. 12, 3173–3180 (1973a).
Bralet, J., Rochette, L.: Effect of Clonidine on the turnover rate of noradrenaline in peripheral tissues of the rat. Europ. J. Pharmacol. 23, 239–244 (1973b).
Bralet, A.M., Rochette, L., Bralet, J.: Influence de la Clonidine sur les débits sanguins nutritionnels et les résistances vasculaires régionales chez le rat normotendu et hypertendu. J. Pharmacol. (Paris), 5, 87–100 (1974).
Bralet, J., Rochette, L., Bralet, A.M.: Influence de la Clonidine sur la synthèse et la libération de la noradrenaline chez le rat. J. Pharmacol. (Paris) 4, 416–417 (1973c).
Brest, A.N.: Pharmacodynamic effects of Catapress. In: Conolly, M.E. (Ed.): Catapress in hypertension, pp. 71–77. London: Butterworths 1970.
Briant, R.H., Reid, J.L.: Desmethylimipramine and the hypotensive action of Clonidine in the rabbit. Brit. J.. Pharmacol. 46, 563P–564P. (1972).
Briant, R.H., Reíd, J.-L., Dollery, C.T: Interaction betweens Clonidine and desipramine in man. Brit. Med. J. 1973 I, 522.
Brod, J., Horbach, L., Just, H, Rosenthal, J., Nicolescu, R.: Acute effects of Clonidine and central and peripheral haemodynamics on plasma renin activity. Europ. J. Clin Pharmacol. 4, 107–111 (1972).
Brodie, D.A., Lotti, V.J., Bauer, B.G.: Drug effects on gastric secretion and stress gastric hemorrhage in the rat. Amer. J. dig. Dis. 15, 111–120 (1970).
Broekkamp, C.L.E., Struyker-Boudier, H.A.J., vanRossum, J.M.: The involvement of catecholaminergic receptors in the regulation of feeding behavior. In: Milliez, P., Safar, M. (Eds.): Recent Advances in Hypertension. Vol. 2, pp. 99–106. Reims: Société Aliéna 1975.
Broeexamp, C, Van Rossum, J.M.: Clonidine-induced intrahypothalamic stimulation of eating in rats. Psychopharmacologia 25, 162–168 (1972).
Bucht, H., Bergquist-Poppen, M., Bergstrom, J., Bozovic, L., Castenfors, J.: The effect of Catapresan on the renal circulation and the plasma renin activity. In: Hedlmeyer, Holt-meier, Pfeiffer (Eds.): Hochdrucktherapie, pp. 124–128. Stuttgart: Thieme 1968.
Castro de la Mata, R., Penna, M., Aviado, D.M.: Reversal of sympathomimetic bronchodilatation by dichloro-isoproterenol. J. Pharmacol, exp. Ther. 135, 197–303 (1962).
Chasin, M., Rivkin, L, Mambak, F., Samaniago, S.G., Hess, S.M.: α- and β-adrenergic receptors as mediators of accumulation of cyclic adenosine 3’, 5’ monophosphate in specific areas of guinea pig brain. J. biol. Chem. 246, 3037–3041 (1971).
Chevillabd, C., Pasqtjiebj, R., Alexandre, J. M., Schmitt, H.: Actions périphériques et centrales d’agents alphα-sympathomimétiques (Clonidine et naphazoline) sur l’activité reniñe plasmatique du rat. J. Pharmacol. (Paris) 7, 457–467 (1976).
Cho, A.K., Cubby, S.H.: The physiological disposition of 2-(2, 6 dichloro-anilino)-2-imidazoline (St 165). Biochem. Pharmacol. 18, 511–520 (1969).
Cho, A. K., Cubby, S. H., Jacobsen, S.: Localisation of basic drugs in the submaxillary gland. Biochem. Pharmacol. 18, 2323–2330 (1969).
Chbystans, S.G., Lavendeb, A.R.: Direct renal hemodynamic effects of Clonidine. Arch. int. Pharmacodyn. Therap. 218, 202–211 (1975).
Constantine, J. W., McShane, W.K.: Analysis of the cardiovascular effects of 2-(2, 6-dichloro-phenylamino)-2-imidazoline hydrochloride (Catapres®). Europ. J. Pharmacol. 4, 109–123 (1968).
Coote, J.H., Downmann, C.B.B.: Central pathways of some autonomic reflex discharges. J. Physiol. (Lond.) 183, 714 (1966).
Cosniee, D., Gbimal, J., Cheucle, M., Stbeichenbebgeb, G.: Influence de Phypercapnie sur les effects circulatoires cérébraux de la Clonidine chez l’animal éveillé. J. Pharmacol. (Paris) 4, 505–519(1973).
Coupae, I.M., Kibby, M.J.: The effect of Clonidine on human isolated smooth muscle. Europ. J. Pharmacol. 17, 50–58 (1972).
Coupab, I.M., Tubneb, P.: Relative affinities of some α-adrenoreceptor blocking drugs in isolated human smooth muscle. Brit. J. Pharmacol. 40, 155P–157P (1970).
Cbill, W.E., Reis, D. J.: Distribution of carotid sinus and depressor nerves in cat brain stem. Amer. J. Physiol. 214, 269–276 (1968).
Csongbady, A., Kobingee, W.: Investigations into the positive inotropic effect of Clonidine in isolated hearts. Arch. Pharmacol. 281, 123–128 (1974).
Cuewainjb, P., Endebsby: Enhancement of pentagastrin induced gastric acid secretion by Clonidine in the conscious dog. Brit. J. Pharmacol. 50, 431–434 (1974).
Dahlstböm, A., Fuxe, K.: Evidence for the existence of monoamine-containing neurones in the central nervous system. Acta physiol. scand. 62, Suppl. 232 (1964).
Dabda, S.: Pharmacokinetics of Clonidine. In: Milliez, P., Safab, M. (Eds.): Recent advances in hypertension. Vol. 2, pp. 375–388. Reims: Société Aliéna 1975.
Davidovj, M., Kakaviatos, N., Finnebty, Fa.JB.: The antihypertensive properties of an imidazoline compound (St 155). Amer. J. Cardiol. 19, 125–126 (1967).
Day, M.D., Roach, A.G.: Central α- and β-adrenoceptors modifying arterial blood pressure and heart rate in conscious cats. Brit. J. Pharmacol. 51, 525–533 (1974).
Daskalopoulos, N.Th., Schmitt, H., Cottebeau, M.-J., Denikeb, P.: Unpublished data (1977).
Deck, R., Obebdobf, A., Kbonebebg, G.: Die Wirkung von 2-(2, 6-Dichlorophenylamino)-2-imidazolin-hydrochlorid (Clonidin) auf die Kontraktion und die Acetylcholin-Freisetzung am isolierten, koaxial elektrisch gereizten Meerschweinchenileum. Arzneimittel-Forsch. 21, 1580–1584 (1971).
Decrees, W., Rehbindeb, D.: Resorption, Verteilung, Ausscheidung und Metabolismus von Catapresan. In: Heilmeyeb, Holtmeiee, Pfeiffee (Eds.): Hochdrucktherapie, S. 17–26. Stuttgart: Thieme 1968.
DeGboat, W., Douglas, J., Lalley, P.: Effects of Clonidine, L-dopa and L-5-HTP on spinal and supraspinal sympathetic reflexes elicited by visceral and somatic afferent stimulation. Sixth International Congress of Pharmacology, Helsinski Abstract n° 1262, p. 52 (1975).
Delbabee, B.: Sedative effects of α-sympathomimetic agents. In: Milliez, P., Safae, M. (Eds.): Recent advances in hypertension, Vol. 2, pp. 87–97. Reims: Société Aliéna 1975.
Delbabbe, B., Schmitt, H.: Influences pharmacologiques exercées sur la durée du sommeil provoqué chez le poussin par la 2-(2, 6-dichlorophénylamino)-2-imidazoline (Stl55, Catapresan®) C. R. Soc. Biol. (Paris) 163, 1922–1926 (1969).
Delbabee, B., Schmitt, H.: Sedative effects of α-sympathomimetic drugs and their antagonism by adrenergic and cholinergic blocking drugs. Europ. J. Pharmacol. 13, 356–363 (1971).
Delbaebe, B., Schmitt, H.: A further attempt to characterize sedative receptors activated by Clonidine in chickens and mice. Europ. J. Pharmacol. 22, 355–359 (1973).
Delbabee, B., Schmitt, H.: Action of Clonidine and α-adrenoreceptor blocking agents on conditioned avoidance reflexes in rats: their interactions and antagonism with atropine. Psychopharmacologia 35, 195–202 (1974).
Delbeück, O.: Ergebnisse toxikologischer und teratologischer Tierversuche mit 2-(2, 6-Dichlorophenylamino)-2-Imidazolin-hydrochlorid. Arzneimittel-Forsch. 16, 1053–1055 (1966).
Dhawan, B.N., Johri, M.B., Srimal, R.C., Viswesaram, D.: A study in cat of the effect of Clonidine on central vasomotor loci. Arch. Pharmacol. 279, Suppl. R22 (1973).
Dhawan, B.N., Johri, M.B., Sing, G.B., Srimal, R.C., Visweraman, D.: Effect of Clonidine on the excitability of vasomotor loci in the cat. Brit. J. Pharmacol. 54, 17–21 (1975a).
Dhawan, B.N., Singh, G.B., Srimal, R.C: The effect of Clonidine on some centrally evoked cardiovascular responses. In: Milliez, P., Safar, M. (Eds.): Recent Advances in Hypertension. Vol. 1, pp. 111–124. Reims: Société Aliéna 1975b.
Diesenhammer, E., Klausberger, E. M.: Die cerebrale Hämodynamik unter der Einwirkung von 2-(2, 6-Dichlorophenylamino)-2-Imidazolin-hydrochlorid. Arzneimittel-Forsch. 16, 1161–1162 (1966).
Dollery, C.T., Davies, D.S., Draffan, G.H., Dargie, H.J., Dean, C.R., Reid, J.L., Clare, R. A., Murray, S.: Clinical pharmacology and pharmacokinetics of Clonidine. Clin. Pharmacol. Therap. 19, 11–17 (1976).
Dollery, C.T., Reíd, J.L.: Central noradrenergic neurones and the cardiovascular actions of Clonidine in the rabbit. Brit. J. Pharmacol. 47, 206–216 (1973).
Drew, G.M.: Effects of α-adrenoceptor agonists and antagonists on pre- and post-synaptically located α-adrenoceptors. Europ. J. Pharmacol. 36, 313–320 (1976).
Duchêne-Marullaz, P., Delort, P., Cosnier, D.: De l’action bradycardisante de la Clonidine (St 155). J. Pharmacol. (Paris) 1, 425 (1970).
Edis, A.J., Shepherd, J.T.: Selective denervation of aortic arch baroreceptors and chemore- ceptors in dogs. J. appl. Physiol. 30, 294–296 (1971).
Edelhauser, E.M.: Erfahrungen mit der lokalen Applikation von Clonidin beim Glaukom. Klin. Mbl. Augenheilk. 158, 514–517 (1971).
Ehrhardt, J.D.: Synthèse de la Clonidine marquée et étude de son métabolisme chez le rat. J. Pharmacol. (Paris) 3, 256–267 (1972 a).
Ehrhardt, J.D.: Métabolisme du Catapressan: Action hypotensive du 4-hydroxy-catapressan. Thérapie 27, 947–954 (1972b).
Ehringer, H.: Die Wirkung von 2-(2, 6-Dichlorophenylamino)-2-Imidazolin-hydrochlorid auf die Extremitätendurchblutung, den Blutdruck und die Venenkapazität bei Normotonikern. Arzneimittel-Forsch. 16, 1165–1169 (1966).
Farnebo, L.D., Hamburger, B.: Drugs-induced changes in the release of 3H-noradrenaline from field stimulated rat iris. Brit. J. Pharmacol. 43, 97–106 (1971).
Fehn, P.A., Lindsay, L. A., Kirsten, W.: Evidence for a decreased venous return caused by Clonidine. Fifth International Congress on Pharmacology. Abstracts of Volunteer papers p. 67 (398) (1972).
Finch, L.: The cardiovascular effects of intraventricular Clonidine and BAY 1470 in conscious hypertensive cats. Brit. J. Pharmacol. 52, 333–338 (1974).
Finch, L., Buckingham, U.E., Moore, R. A., Bûcher, T.J.: Evidence for a central α-sympathomimetic action of Clonidine in the rat. J. Pharm. Pharmacol. 27, 181–185 (1975a).
Finch, L., Hersom, A., Hicks, P.: The central regulation of blood pressure by sympathomimetics. In: Milliez, P., Safar, M. (Eds.): Recent Advances in Hypertension, Vol. 1, pp. 73–83. Reims: Société Aliéna 1975b.
Finch, L., Hicks, P.E.: No evidence for central histamine-receptor involvement with the hypotensive effects of Clonidine in cats. Europ. J. Pharmacol. 40, 365–368 (1976).
Finnerty, F. A.: Evaluation of the anti-hypertensive effects of Catapres in man. In: Conolly, M.E. (Ed.): Catapres in hypertension, pp. 155–165. London: Butterworths 1970.
Florio, V., Bianchi, L., Longo, V.G.: A study of the central effects of sympathomimetic drugs: EEG and behavioural investigations on Clonidine and naphazoline. Neuropharmacology 14, 707–714 (1975).
Fozard, J.R.: Clonidine and methysergide: effects on isolated artery. Arch. Pharmacol. 279 Suppl. R21 (1973).
Frank, H., Loewenich-Lagois, K.von: Therapeutische Prüfung und Untersuchungen zur Nierenfunktion mit einer neuen blutdrucksenkenden Substanz (St 155). Dtsch. med. Wschr. 91, 1680–1686 (1966).
Franz, D.N., Hare, B.D., Neumayr, R.J.: Reciprocal control of sympathetic preganglionic neurons by monoaminergic, bulbospinal pathways and a selective effect of Clonidine. In: MrLuez, P., Safar, M. (Eds.): Recent Advances in Hypertension, Vol. 1, pp. 85–96. Reims: Editions Aliéna 1975.
Frydman, A., Weiss, Y., Saear, M., Alexandre, J. M.: Pharmacokinetics of Clonidine in man (preliminary results). In: Milliez, P., Safar, M. (Eds.): Recent Advances in Hypertension, Vol. 2, pp. 369–374. Reims: Société Aliéna 1975.
Fügner, A.: Antagonism of the drug-induced behavioural sleep in chicks. Arzneimittel-Forsch. 21, 1350–1352 (1971).
Fügner, A., Hoefke, W.: A sleep-like state in chicks caused by biogenic amines and other compounds: quantitative evaluation. Arzneimittel-Forsch. 21, 1243–1247 (1971).
Ganong, W.F.: Brain amines and the control of ACTH and growth hormone secretion. In: Motta, M., Crosignani, P.G., Martini, L. (Eds.): Hypothalamic Hormones, pp. 237–248. London-New York-San Francisco: Academic Press 1975a.
Ganong, W. F., Reíd, I. A., Loviistger, R. D., Kaplan, S. L.: Neuroendocrine effects of Clonidine. Sixth International Congress of Pharmacology, Abstracts, p. 93 (n° 200). Helsinki, Finland (1975b).
Gelinov, Chr., Belove jdoc, N.: Klinische Untersuchungen über die Beeinflussung der Acidität der Magensekretion durch Catapresan. Verh. dtsch. Ges. inn. Med. 76, 160–163 (1970).
Gilbert, J.C., Ribeyro, F., Graisley, B., Touboul, J.P.: Régulation monoaminergique centrale de l’hormone de croissance (submitted).
Gillis, R.A., Dionne, R.A., Standaert, F.G.: Suppression by Clonidine (St 155) of digitalis-induced arrhythmias. Pharmacologist 13, 225 (1971).
GiLLis, R.A., Dionne, R.A., Standaert, F.G.: Suppression by Clonidine (St 155) of digitalis induced arrhythmias. J. Pharmacol, exp. Therap. 182, 218–226 (1972).
Giudicelli, R., Beauvallet, M., Chabrier, P., Najer, H.: Sur l’action vasculaire de quelques amino-2-oxazolines N-substituées. C. R. Acad. Sci. (Paris) 247, 891–893 (1958).
Giudicelli, R., Schmitt, H.: Propriétés antihypertensives et mécanisme d’action de la (diméthyl-2–6-phénylamino)-2Δ 2-oxazoline-l, 3. J. Pharmacol. (Paris) 1, 339–358 (1970).
Glick, S.D., Cox, R.D.: Differential sensitivity to apomorphine and Clonidine following cortical damage in cats. Europ. J. Pharmacol. 36, 241–246 (1976).
Gogolak, G., Stumpf, Ch.: Wirkung von 2-(2, 6-Dichlorophenylamino)-2-Imidazolin-hydro-chlorid auf die EEG-Weckreaktion beim Kaninchen. Arzneimittel-Forsch. 16, 1050–1052 (1966).
Grabner, G., Michalek, P.: Einige experimentelle Erfahrungen mit Catapresan. In: Hellmeyer, Holtmeier, Pfeiffer (Eds.): Hochdrucktherapie, S. 49–55. Stuttgart: Thieme 1968.
Grabner, G., Michalek, P., Pokorny, D., Vormittag, E.: Klinische und experimentelle Untersuchungen mit der neuen blutdrucksenkenden Substanz 2-(2, 6-Dichlorophenylamino)-2-Imidazolin-hydrochlorid. Arzneimittel-Forsch. 16, 1174–1176 (1966).
Graubner, W., Wolf, M.: Kritische Betrachtungen zum Wirkungsmechanismus des 2-(2, 6-Dichlorophenylamino)-2-Imidazolin-hydrochlorids. Arzneimittel-Forsch. 16, 1055–1058 (1966).
Green, J.R., Heffron, P.F.: Studies upon patterns of activity in single postganglionic sympathetic fibres. Arch. int. Pharmacodyn. Therap. 173, 232–243 (1968).
Gut, J.-P., Schmitt, H.: Action de la 2-(2, 6-dichlorophénylamino)-2-imidazoline (St 155, Catapresan®) sur quelques réflexes cardiovasculaires du lapin. C. R. Soc. Biol. (Paris) 164, 880–883 (1970).
Haan, D.: Kontinuierliche automatische Blutdruckregistrierung nach Verabreichung einer neuen antihypertensiven Substanz. Arzneimittel-Forsch. 16, 1180–1183 (1966).
Haan, D.: Cardiale Kontraktionskraft und kontinuierliche Langzeitkontrolle der Kreislaufwerte unter 2-(2, 6-Dichlorophenylamino)-2-Imidazolin-hydrochlorid. In: Heilmeyer, Holtmeier, Pfeiffer (Eds.): Hochdrucktherapie, S. 55–60. Stuttgart: Thieme 1968.
Haefely, W.E., Jalfre, M., Monachon, M. A.: Drug-induced PGO wawes: a neuropharmα-cological method for evaluating agents which interact with central norepinephrine (NE) and serotonin (5 HT) neurons or receptors. Fifth international Congress on Pharmacology. Volunteer papers p. 93, (558) (1972).
Haeusler, G.: Activation of the central pathway of the baroreceptor reflex, a possible mechanism of the hypotensive action of Clonidine. Arch. Pharmacol. 278, 231–246 (1973a).
Haeusler, G.: Clonidine and the baroreceptor reflex. Arch. Pharmacol. 279, Suppl. R22, 31 (1973).
Haeusler, G.: Sympathetic nerve activity after noradrenaline depletion and its alteration by Clonidine. Arch. Pharmacol. 282, R29 (1974a).
Haeusler, G.: Further similarities between the action of Clonidine and a central activation of the depressor baroreceptor reflex. Arch. Pharmacol. 285, 1–14 (1973b).
Haeusler, G.: Clonidine induced inhibition of sympathetic nerve activity: no indication for a central presynaptic or indirect sympathomimetic mode of action. Arch. Pharmacol. 286, 97–111 (1974c).
Haeusler, G.: Studies on the possible contribution of a peripheral presynaptic action of Clonidine and dopamine to their vascular effects under in vivo conditions. Arch. Pharmacol. 295, 191–202 (1976).
Haeusler, G., Finch, L.: On the nature of the central hypotensive effect of Clonidine and a methyldopa. J. Pharmacol. (Paris) 3, 544–545 (1972).
Haeusler, G., Lewis, P.: The baroreceptor reflex and its relations to central adrenergic mechanisms. In: Milliez, P., Safar, M. (Eds.): Recent Advances in Hypertension, Vol. 1, pp. 17–26. Reims: Société Aliéna 1975.
Hasslinger, C: Catapresan [2-(2, 6-Dichlorophenylamino)-2-Imidazolin-hydrochlorid], ein neues augendrucksenkendes Medikament. Klin. Mbl. Augenheilk. 154, 95–105 (1969).
Heilmann, K.: Catapresan and Catapresan-Kombination in der Glaukombehandlung. Sitzungsbericht der 120. Versammlung der Verein. Rhein. Westf. Augenärzte (1969).
Heilmann, K.: Untersuchungen über Wirkung von Catapresan auf den intraokulären Druck. 1. Mitteilung. Klin. Mbl. Augenheilk. 157, 182–192 (1970).
Heilmann, K.: Untersuchungen über die Wirkung von Catapresan auf den intraokularen Druck. 2. Mitteilung. Klin. Mbl. Augenheilk. 158, 493–500 (1971).
Heise, A., Kroneberg, G.: Periphere und zentrale Kreislaufwirkung des α-Sympathomimeticums 2-(2, 6-Xylidino)5, 6-dihydro-4H-l-3-thiazinhydrochlorid (BAY 1470). Arch. Pharmakol. 266, 350–351 (1970).
Heise, A., Kroneberg, G., Schlossmann, K.: α-sympathomimetische Eigenschaften als Ursache der blutdrucksteigenden und blutdrucksenkenden Wirkung von BAY 1470 (2-(2, 6-Xylidino)5–6-dihydro 4H-l-3-thiazin-hydrochlorid. Arch. Pharmakol. 208, 348–360 (1971).
Henning, M., Stock, G., Trolin, G.: Circulatory effects of Clonidine after prehypothalamic section of the brain stem. Acta Pharmacol. Toxicol. 38, 376–381 (1976).
Hild, R., Dietz, R.: Über die Wirkung von Catapresan auf die Volumenpulsamplitude der Haut, den Blutdruck und die Pulsfrequenz bei Gesunden. In: Heilmeyer, Holtmeier, Pfeiffer (Eds.): Hochdrucktherapie, S. 60–63. Stuttgart: Thieme 1968.
Hodge, R.L., Robinson, S.M.: Vascular actions of Clonidine in man. Brit. J. Pharmacol. 40, 573P–574P (1970).
Hodges, P.: Identification of 2, 6-dichlorophenylguanidine as a metabolite of Clonidine. J. Pharm. Pharmacol. 28, 61–62 (1976).
Hoefke, W.: Effects of Clonidine and clonidine-like substances on gastric secretion in rats Sixth International Congress of Pharmacology. Abstracts, p. 119 (n° 278) (1975).
Hoefke, W., Kobinger, W.: Pharmakologische Wirkungen des 2-(2, 6-Dichlorophenyiamino)-2-Imidazolin-hydrochlorids, einer neuen antihypertensiven Substanz. Arzneimittel-Forsch. 16, 1038–1056 (1966).
Hoefke, W., Kobinger, W., Walland, A.: Relationship between activity and structure in derivatives of Clonidine. Arzneimittel-Forsch. 25, 786–793 (1975).
Hoefke, W., Warnke-Sachs, E.: Influence of desmethylimipramine on the hypotensive effect of Clonidine. Arzneimittel-Forsch. 24, 1046–1047 (1974).
Hoffmeister, F.: On the possible relations between postganglionic adrenergic and cholinergic neurone blockade demonstrable in the peripheral autonomous system and central analgesia. The analgesic activity of BAY 1470 and its relation to morphine analgesia. In Pain: Soulairac, A., Cahn, J., Charpentier, J. (Eds.), pp. 281–298. London-New York: Academic Press 1968.
Hökfelt, T., Dymling, J.F., Hedeland, H.: The effect of Catapresan on urinary catecholamines, plasma renin and urinary aldosterone in hypertensive patients. In: Heilmeyer, Holtmeier, Pfeiffer (Eds.): Hochdrucktherapie, S. 105–108. Stuttgart: Thieme 1968.
Höeeltj B, Hedeland, J, Dymling, J.F.: Studies on catecholamines, renin and aldosterone following Catapresan® [2-(2, 6-dichlorophenylamino)-2-imidazólin] in hypertensive patients. Europ. J. Pharmacol. 10, 389–397 (1970a).
Hökfelt, B., Hedeland, H., Dymling, J. F.: The influence of Catapresan on catecholamines, renin and aldosterone in man. In: Conolly, M.E. (Ed.): Catapresan in Hypertension, pp. 85–98. London: Butterworths 1970b.
Hökfelt, B., Hedeland, H., Hansson, B.G.: The effects of Clonidine and Penbutolol, respectively on catecholamines in blood and urine, plasma renin activity and urinary aldosterone in hypertensive patients. Arch. int. Pharmacol. Therap. 213, 307–321 (1975).
Holman, R.B., Smllrro, E.E., Vogt, M.: Sleep produced by Clonidine [2-(2, 6-dichlorophenyl-amino)-2-imidazoline hydrochloride]. Brit. J. Pharmacol. 43, 685–695 (1971).
Hukuhara, T.J., Otsuka, Y., Tadeka, R., Sarai, F.: Die zentralen Wirkungen des 2-(2, 6-Dichlorophenylamino)-2-Imidazolin-hydrochlorids. Arzneimittel-Forsch. 18, 1147–1153 (1968).
Humphrey, M.H., Reíd, I.A.: Acute effect of Clonidine on renal water excretion. Clin. Res. 22, 532A (1974).
Hunt, G.E., Atrens, D.M., Chescher, G.B., Belcker, F.T.: α-noradrenergic modulation of hypothalamic self-stimulation; studies employing Clonidine, 1-phenylephrine and α-methyl- p-tyrosine. Europ. J. Pharmacol. 37, 105–111 (1976).
Iwata, Y.: Hyperglycaemic action of 2-(2, 6-dichlorophenylamino)-2-imidazoline hydrochloride in relation to its hypertensive effects. Jap. J. Pharmacol. 19, 249–259 (1969).
Jacobs, F., Werner, U., Schümann, H.J: Zum Mechanismus der antihypertensiven Wirkung des Oxazolin-Derivates BAY a 6781. Arzneimittel-Forsch. 22, 1124–1126 (1972).
James, I.M., Labbi, E., Zaimis, E.: The effect of the acute intravenous administration of Clonidine (St 155) on cerebral blood flow in man. Brit. J. Pharmacol. 39, 198P–199P (1970).
Jennewein, H.M.: The effect of Clonidine on gastric acid secretion in rats and dogs. Arch. Pharmacol. 297, 85–90 (1977).
Jouvetj, M., Renault, J.: Insomnie persistante après lésions des noyaux du raphe chez le chat. C. R. Soc. Biol. (Paris) 160, 1461–1465 (1966).
Juenemann, G., Patjst, E.: Über Wirkungsweise und Wirkungsprinzip des Catapresan in der Glaukomtherapie. Klin. Mbl. Augenheilk. 158, 501–513 (1971).
Jtjenemann, G., Schmidt, G.: Zur Catapresanwirkung am Glaucomatosenauge. Klin. Mbl. Augenheilk. 157, 193–201 (1970).
Kaess, H., Mikulicz-Radecki, J. von: Der Einfluß von 2-(2, 6-Dichlorophenylamino)2-Imidα-zolin-hydrochlorid (Catapresan®) auf die Funktion von Magen und Pankreas. Europ. J. clin. Pharmacol. 3, 97–101 (1971).
Kaplan, H.R., LaSala, S.A., Simon, A., Robson, R.D.: St 155-induced cardiac slowing in dogs. Europ. J. Pharmacol. 6, 193–196 (1969).
Karppanen, H., Paakkari, L, Paakkari, P., Huotari, R., Orma, A.L.: Possible involvement of central histamine H2-receptors in the hypotensive effect of Clonidine. Nature (Lond.) 259, 587–588 (1976).
Karppanen, H.O., Westermann, E.: Increased production of cyclic AMP in gastric tissue by stimulation of Histamine (H2) receptors. Arch. Pharmacol. 279, 83–87 (1973).
Katic, F., Lavery, H., Lowe, R.D.: The central action of Clonidine and its antagonism. Brit. J. Pharmacol. 44, 779–787 (1972).
Kho, T.L., Schalekamp, A.D.H., Zaal, G.A., Wester, A., Birgenhäger, W.H.: Comparison between the effects of St 600 and Catapres. Arch. int. Pharmacod. Therap. 214, 347–350 (1975).
Kho, T.L., Schalekamp, A.D.N., Zaal, G.A., Wester, A., Birgenhäger, W.H.: Comparison between the effects of St 600 and Clonidine. Arch. int. Pharmacod. Therap. 217, 162–169 (1975).
Kirchertz, E.J., Peters, G.: The effect of Clonidine (Catapres®) and other hypotensive agents on plasma renin activity. Experientia (Basel) 29, 764 (Abst.) (1973).
Kirchhoff, H.W.: Lungenfunktionsprüfungen und leitungsmedizinische Untersuchung über die Wirkung von Catapresan bei gesunden Versuchspersonen. In: Heilmeyer, Holtmeier, Pfeiffer (Eds.): Hochdrucktherapie. Stuttgart: Thieme 1968.
Kntpekar, S.M., Puig, M.: Effect of flow stop on noradrenaline release from normal spleens and spleens treated with cocaine, phentolamine or phenoxybenzamine. Brit. J. Pharmacol. 43, 359–369 (1971).
Kleinlogel, H., Scholtysik, C., Sayers, A.C: Effects of Clonidine and BS 100–141 on the EEG sleep pattern in rat. Europ. J. Pharmacol. 33, 159–163 (1975).
Klevans, L.R., Kepner, K., Kovacs, J.C.: Role of forebrain in clonidine-induced suppression of cardiovascular responses. Europ. J. Pharmacol. 24, 262–265 (1973).
Kltjpp, H., Knappen, F., Otsuka, Y., Streller, L, Teichmann, H.: Effects of Clonidine on central sympathetic tone. Europ. J. Pharmacol. 10, 225–229 (1970).
Knobloch, H., Morr, H.: Einzeldosisstudien zur Wirkung von 2-(2, 6-Dichlorophenylamino) 2-Imidazolin-hydrochlorid auf Blutdruck und Puls bei Hypertonikern und zur Verträglichkeit. Arzneimittel-Forsch. 16, 1169–1174 (1966).
Kobinger, W.:Über den Wirkungsmechanismus einer neuen antihypertensiven Substanz mit Imidazolinstruktur. Arch. Pharm, exp. Path. 258, 48–68 (1967).
Kobinger, W.: Die Wirkung von 2-(2, 6-Dichlorophenylamino)-2-Imidazolin-hydrochlorid (St 155, Catapres®) auf die Harnausscheidung von osmotisch freiem Wasser. Arch. Pharm. exp. Path. 260, 153–154 (1968).
Kobinger, W.: Die Beeinflussung des Tauchreflexes durch sympathicushemmende Antihypertensiven. Arch. Pharm, exp. Path. 264, 256–257 (1969).
Kobinger, W.: Comparison of peripheral and central effects of Catapres® (St 155, 2-(2, 6-dichlorophenylamino)-2-imidazolin hydrochloride) on the sympathetic nervous system. In: Conolly, M.E. (Ed.): Catapres in Hypertension, pp. 43–50. London: Butterworths 1970.
Kobinger, W.: In: Kim, K.E., Moyer, J.H. (Eds.): Pharmacological basis of the cardiovascular actions of Clonidine in hypertension: Mechanism and Management. G.Onesti, pp. 369–380. New York-London: Grune & Stratton 1971.
Kobinger, W., Hoefke, W.: Pharmakologische Untersuchungen über den Angriffspunkt und Wirkungsmechanismus eines neuen Hochdruckmittels. In: Heilmeyer, Holtmeier, Pfeif-fer (Eds.): Hochdrucktherapie, S. 4–17. Stuttgart: Thieme 1968.
Kobinger, W., Oda, M.: Effects of sympathetic blocking substances on the diving reflex of ducks. Europ. J. Pharmacol. 7, 289–295 (1969).
Kobinger, W., Pichler, L.: Evidence for direct α-adrenoceptor stimulation of effector neurons in cardiovascular centers by Clonidine. Europ. J. Pharmacol. 22, 151–154 (1974).
Kobinger, W., Pichler, L.: Localization into the central nervous system of adrenoceptors which facilitate a cardioinhibitory reflex. Arch. Pharmacol. 286, 371–377 (1975a).
Kobinger, W., Pichler, L.: The central modulatory effect of Clonidine on the cardiodepressor reflex after suppression of synthesis and storage of noradrenaline. Europ. J. Pharmacol. 30, 56–62 (1975b).
Kobinger, W., Pichier, L.: Investigation into some imidazoline compounds, with respect to peripheral α-adrenoceptor stimulation and depression of cardiovascular centers. Arch. Pharmacol. 291, 175–191 (1975c).
Kobinger, W., Pichler, L.: Centrally induced reduction in sympathetic tone-a postsynaptic α-adrenoceptor stimulating action of imidazolines. Europ. J. Pharmacol. 40, 311–320 (1976).
Kobinger, W., Walland, A.: Untersuchungen über den Wirkungsmechanismus von 2-(2, 6-Dichlorophenylamino)-2-Imidazolin-hydrochlorid (Catapresan, St 155). Arch. Pharm, exp. Path. 257, 291–292 (1967a).
Kobinger, W., Walland, A.: Circulatory studies with 2-(2, 6-dichlorophenylamino)-2-imidazoline hydrochloride. Arzneimittel-Forsch. 17, 292–300 (1967b).
Kobinger, W., Walland, A.: Investigations into the mechanism of the hypotensive effect of 2-(2, 6-dichlorophenylamino)-2-imidazolineHCl. Europ. J. Pharmacol. 2, 155–162 (1967 c).
Kobinger, W., Walland, A.: Involvement of adrenergic receptors in central vagus activity. Europ. J. Pharmacol. 16, 120–122 (1971a).
Kobinger, W., Walland, A.: Enhancement of vagal reflex bradycardia by Clonidine: peripheral or central nervous effect ? Acta pharmacol. 29, suppl. 4, 25 (1971b).
Kobinger, W., Walland, A.: Involvement of adrenergic neurones within the CNS in vagally mediated cardiodepressor reflexes. Arch. Pharmakol. 274, Suppl., R67 (1972a).
Kobinger, W., Walland, A.: Evidence for a central activation of a vagal cardiodepressor reflex by Clonidine. Europ. J. Pharmacol. 19, 203–209 (1972b).
Kobinger, W., Walland, A.: Facilitation of vagal bradycardia by an action of Clonidine on central α-receptors. Europ. J. Pharmacol. 19, 210–217 (1972 c).
Kobinger, W., Walland, A.: Modulating effect of central adrenergic neurones on a vagally mediated cardioinhibitory reflex. Europ. J. Pharmacol. 22, 344–350 (1973).
Koch, G.: Hemodynamic effects of 2-(2, 6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155) at rest and during exercise with special respect to the pulmonary circulation. Arzneimittel-Forsch. 21, 57–61 (1971).
Kochsiek,J., Fritschej, H.: Die Wirkung eines Imidazolin-Derivates auf den arteriellen Blutdruck, die Hämodynamik und die Ventilation. Arzneimittel-Forsch. 16, 1154–1160 (1966).
Korner, P., Oliver, J., Sleight, P., Chalmers, J., Robinson, J.: Effects of Clonidine on the baroreceptor heart rate reflex and on single aortic baroreceptor fibre discharge. Europ. J. Pharmacol. 28, 189–198 (1974).
Körner, P., Oliver, J., Sleight, P., Robinson, S., Chalmers, J.: Assessment of cardiac autonomic excitability in renal hypertensive rabbits using Clonidine induced resetting of the baroreceptor heart rate reflex. Europ. J. Pharmacol. 37, 381–384 (1976).
Koss, M.C: Studies on the site of action of Clonidine utilizing a sympathetic cholinergic system. Europ. J. Pharmacol. 37, 381–384 (1976).
Koss, M.C, Davison, M.H.: The electrodermal response as a model for central sympathetic sreactivity: the action of Clonidine. Europ. J. Pharmacol. 37, 71–78 (1976).
Kraemer, D., Krause, W., Renner, H.: Bericht über eine Langzeitprüfung mit 2-(2, 6-Diehloro-phenylamino)-2-Imidazolin-hydrochlorid unter besonderer Berücksichtigung der Wirkung auf den Blutdruck und des Kohlenhydrat-Stoffwechsels. Arzneimittel-Forsch. 20, 519–521 (1970).
Krause, W.: Catapresanbehandlung mit Funktionprüfung des Inselorgans (Tolbutamid-Test) bei nicht diabetischen Hypertoniken. In: Heilmeyer, Holtmeier, Pfeiffer(Eds.): Hochdrucktherapie, S. 147–148. Stuttgart: Georg Thieme 1968.
Kroetz, F.W., McRaven, D., Kioschos, J.M., Klrkendall, W.M.: The acute effects of Catapres on cardiac haemodynamics of hypertensive man. In: Conolly, M.E. (Ed.): Catapres in hypertension, pp. 59–70. London: Butterworths 1970.
Kroneberg, G., Oberdorf, A., Hoffmeister, F., Wirth, W.: Adrenergisch-cholinergische Neuronhemmstoffe. Naturwissenschaften 53, 502 (1966).
Kroneberg, G., Oberdorf, A., Hoffmeister, F., Wirth, W.: Zur Pharmakologie von 2-(2, 6-Dimethylpheny lamino) 4H 5, 6 dihydro-3-thiazin (Bayer 1470), eines Hemmstoffes adrener-gischer und cholinergischer Neurone. Arch. Pharm, exp. Path. 256, 257–280 (1967).
Kündig, H., Monnier, H., Levin, N.W., Charlton, R. W.: Mechanism of action of St 155 on the blood pressure in rats. Arzneimittel-Forsch. 17, 1440–1444 (1967).
Kuljak, S., Stern, P.: Catapresan-induced tremor and its characteristics. Pharmacol. Res. 2, 17–22 (1970).
Langer, S.Z.: The regulation of transmitter release elicited by nerve stimulation through a presynaptic feed-back mechanism. In: Usdin, E., Snyder, S.H. (Eds.): Frontiers in Catecholamines Research, pp. 543–549. New York-Toronto-Oxford-Sidney-Braunschweig: Pergamon Press 1973.
Langer, S.Z.: Presynaptic regulation of catecholamine release. Biochem. Pharmacol. 23. 1773–1800 (1974).
Larbi, E., Zaimis, E.: The effect of the chronic administration of Clonidine (St 155) on vascular smooth muscle. Brit. J. Pharmacol. 39, 221P (1970).
Laubie, M.: Interactions between cholinergic and noradrenergic pathways in central control of blood pressure. In: Milliez, P., Safar, M. (Eds.): Recent Advances in Hypertension, Vol.2, pp. 49–59. Reims: Société Aliéna 1975.
Laubie, M.: Pharmacological evidence for interactions of cholinergic and noradrenergic mechanisms in central cardiovascular control. Proceedings of the Sixth International Congress of Pharmacology. Volume 4, Drug Therapy, pp. 79–85. Helsinki, Finland, 1975.
Latjbie, M., Delbarre, B., Bogaïevsky, D., Bogaïevsky, Y., Tsoucaris-Ktjpfer, D., Senon, D., Schmitt, Hélène, Schmitt, H.: Pharmacological evidence for a central α-sympathomimetic mechanism controlling blood pressure and heart rate. Circulation Res. 38, (suppl. II) 35–41 (1976a).
Laubie, M., Schmitt, H.: Effects hémodynamiques du St 155, (2-(2, 6-dichlorophenylamino)-2-imidazoline) hydrochloride, chez le chien hypertendu. Arch. int. Pharmacodyn. Thérap. 179, 23–35 (1969).
Laubie, M., Schmitt, H.: Influence of autonomic blockade on the reduction in myocardial performance produced by Clonidine. Europ. J. Pharmacol. 25, 56–65 (1974).
Laijbie, M., Schmitt, H.: Sites of action of Clonidine: centrally mediated increase in vagal tone, centrally mediated hypotensive and sympatho-inhibitory effects. In: Hypertension and Brain Mechanisms, de Jongh ed., pp. 337–348, Elsevier, 1977.
Laubie, M., Schmitt, H., Canellas, J., Roqijebert, J., Demichel, P.: Centrally mediated bradycardia and hypotension induced by narcotic analgesics: dextromoramide and fentanyl. Europ. J. Pharmacol. 28, 66–75 (1974).
Laubie, M., Schmitt, H., Drouillat, M.: Action of Clonidine on the baroreceptor pathways and medularry sites mediating vagal bradycardia. Europ. J. Pharmacol. 38, 293–303 (1976b).
Laverty, R.: A comparison of the behavioural effects of some hypotensive imidazoline derivatives in rats. Europ. J. Pharmacol. 9, 163–169 (1970).
Laverty, R., Taylor, K.M.: Behavioural and biochemical effects of 2-(2, 6-dichlorophenyl-amino)-2-imidazoline hydrochloride (St 155) on the central nervous system. Brit. J. Pharmacol. 35, 253–264 (1969).
LeDouarec, J.-C, Schmitt, H., Lucet, B.: Influence of Clonidine and other α-sympathomi- metic agents on water intake in rats. J. Pharmacol. (Paris) 2, 240–241 (1971a).
LeDouarec, J.-C, Schmitt, H., Ltjcet, B.: Influence de la Clonidine et des substances α-sympathomimétiques sur la prise d’eau chez le rat assoiffé. J. Pharmacol. (Paris) 2, 435–444 (1971b).
LeDouarec, J.-C, Schmitt, H., Ltjcet, B.: Effects de la Clonidine et d’autres agents sympathomimétiques sur la prise de nourriture: Antagonisme par des agents adrénolytiques. J. Pharmacol. (Paris) 3, 187–198 (1972).
Lehr, D., Mallon, J., Krokowski, M.: Copious drinking and stimultaneous inhibition of urine flow elicited by beta adrenergic stimulation and contrary effects of alpha adrenergic stimulation. J. Pharmacol, exp. Ther. 158, 150–163 (1967).
Lewis, C. H., Weil, M. H.: Haemodynamic spectrum of vasopressor and dilator drugs. J. Amer. med. Ass. 20P, 1391–1398 (1969).
Li, D.M., Bentley, G.A.: The effect of St 155 on the active reflex vasodilatation induced by adrenaline, noradrenaline and veratrine. Europ. J. Pharmacol. 8, 39–46 (1969).
Li, D.M.P., Bentley, G.A.: The effects of various antihypertensive drugs on the reflex responses to vasoactive substances. Europ. J. Pharmacol. 12, 24–34 (1970).
Lindmar, R., Löffelholz, K., Muscholl, E.: A muscarinic mechanism inhibiting the release of noradrenaline from the peripheral adrenergic nerve fibres by nicotinic agents. Brit. J. Pharmacol. 32, 280–294 (1968).
Lindner, E., Kaiser, J.: Tiamenidine (Hoe 440), a new antihypertensive agent. Arch. int. Pharmacol. Therap. 211, 305–325 (1974).
Lipski, J., Przybylski, J., Solnicka, E.: Reduced hypotensive effect of Clonidine after lesions of the nucleus tractus solitarii in rats. Europ. J. Pharmacol. 38, 19–22 (1976a).
Llyski, J., Solnicka, E.: The effect of activation of central adrenergic receptors by Clonidine on the excitability of the solitary tract neurons in cats. Acta physiol. pol. 27, 309–316 (1976b).
Loew, D.N., Watte, R.: A quantitative assessement of the effects of Clonidine on preganglionic sympathetic nerve activity in the cat. Brit. J. Pharmacol. 50, 456P–457P (1974).
Löffelholz, K., Muscholl, E.: A muscarinic inhibition of noradrenaline release evoked by postganglionic sympathetic nerve stimulation. Arch. Pharmakol. 265, 1–5 (1969).
Lomax, P., Forster, R.S.: Temperature changes induced by imidazoline sympathomimetics in the rat. J. Pharmacol, exp. Ther. 167, 159–165 (1969).
Lombardi, F., Malliani, A., Portillo-Nunez, P., Zaïmis, E., Zanchetti, A.: Peripheral vascular effect of Clonidine independent of a reduction in sympathetic activity. Brit. J. Pharmacol. 57, 448P–449P (1976).
Ludwig, H.: Der Einfluß der Langzeitbehandlung mit 2-(2, 6-Dichlorophenylamino)-2-Imid-azolin HCl auf die Nierenhämodynamik beim arteriellen Hochdruck. Arzneimittel-Forsch. 18, 600–604 (1968).
McCall, R.B., Gebber, G.L.: Differential effect of baroreceptor reflexes and Clonidine on frequency components of sympathetic discharge. Europ. J. Pharmacol. 36, 69–78 (1976).
McRaven, D.R., Kroetz, F.W., Kioschos, J.M., Kirkendall, W.M.: The effect of Clonidine on hemodynamics in hypertensive patients. Amer. Heart. J. 81, 482–489 (1971).
Magus, R. D., Long, J. P.: Mechanism of the hypotensive action of 2-(2, 6-dichIorophenylamino)-2-imidazoline hydrochloride (Stl55) in the cat. J. pharm. Sci. 57, 594–598 (1968).
Maj, J., Sowinska, H., Baran, L., Karturkiewicz, Z.: The effect of Clonidine on locomotor activity in mice. Life Sci. 11, 483–491 (1972).
Makabe, R.: Ophthalmologische Untersuchungen mit Dichlorophenylamino-Imidazolin unter besonderer Berücksichtigung des Einflusses auf den intraokularen Druck. Dtsch. med. Wschr. 91, 1686–1688 (1966).
Makabe, R.: Einfluß von Catapresan auf den Ophthalmica und Augeninnendruck. In: Heilmeyer, Holmeier, Pfeiffer(Eds.): Hochdrucktherapie, S. 64–67. Stuttgart: Thieme 1968.
Maling, H.M., Cho, A.K., Horokova, Z., Williams, M.A.: The pharmacologic effects of St 155 (Catapres) and related imidazolines in the rat. Pharmacology 2, 337–351 (1969).
Maling, H.M., Cho, A., Williams, M. A.: Some central effects of St 155 (Catapres) and related imidazolines in the rat. Pharmacologist 10, 157 (1968).
Marley, E., Nistico, G.: Sleep and hypothermic effects of Clonidine in fowls. Brit. J. Pharmacol. 52, 434P–435P (1974).
Marley, E., Nistico, G.: Central effects of Clonidine, 2-(2, 6-dichlorophenylamino)-2-imidazoline hydrochloride, in fowls. Brit. J. Pharmacol. 55, 459–473 (1975).
Maskrey, M., Vogt, M., Bligh, J.: Central effects of Clonidine [2-(2, 6-dichlophenylamino)-2-imidazoline hydrochloride, St 155] upon thermoregulation in the sheep and goat. Europ. J. Pharmacol. 12, 297–302 (1970).
Maxwell, G.M.: The effects of 2-(2, 6-dichlorphenylamino)-2-imidazoline hydrochloride (Catapres®) upon the systemic and coronary haemodynamics and metabolism of intact dogs. Arch. int. Pharmacodyn. Therap. 181, 7–14 (1969).
Michel, D.: Erfahrungen mit Catapresan in der Hochdrucktherapie. Dtsch. med. Wschr. 93, 1375 (1968).
Michel, D., Zimmermann, W., Nassehi, A., Seraphim, P.: Erste Beobachtungen über einen antihypertensiven Effekt von 2-(2, 6-Dichlorophenylamino)-2-Imidazolin-hydrochlorid am Menschen. Dtsch. med. Wschr. 91, 1540–1547 (1966).
Miura, M., Reis, D. J.: Termination and secondary projections of carotid sinus nerve in the cat brain stem. Amer. J. Physiol. 217, 142–153 (1969).
Morpurgo, C.: Aggressive behaviour induced by large doses of 2-(2, 6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155) in mice. Europ. J. Pharmacol. 3, 374–377 (1968).
Motjret, J., Bobillier, P., Jouvet, M.: Effects de la p-chlorophénylalanine sur le sommeil du rat. C. R. Soc. Biol. (Paris) 161, 1600–1603 (1968).
Muni, A.L.: The circulatory effects of Catapres at rest and exercise. In: Conolly, M.E. (Ed.): Catapres in hypertension, pp. 79–83. London: Butterworths 1970.
Muir, A. L., Burton, J. L., Lawrie, D.M.: Circulatory effects at rest and exercise of Clonidine, an imidazoline derívate with hypotensive properties. Lancet 1969 II, 181–184 (1969).
Natoff, I.L., Katzung, B.G., Weir, F., Kooma, J.K.: Cardiovascular properties of l-(2, 6-dichlorobenzylidene) aminoguanidine hydrochloride (SD 15.488). Pharmacologist 10, 157 (1968).
Natoff, I.L., Stanton, N.C.: Comparative study of the cardiovascular properties of 2-(2, 6-dichlorophenylamino)-2-imidazoline hydrochloride (Catapres) and 2-(2, 6-dichloroben-zylidene) aminoguanidine hydrochloride (SD 15.488). Fourth international Congress on Pharmacology. (Abstracts) 312 (1969).
Nayler, W.G., McInnes, L, Stone, J., Carson, V., Lowe, T.E.: Catapres (Stl55) induced changes in coronary vascular resistance. Cardio vase. Res. 4, 457–465 (1970).
Nayler, W.G., Price, J.M., Stone, J., Lowe, T.E.: Further observations on the cardiovascular effects of St 155 (Catapres). J. Pharmacol, exp. Ther. 166, 364–373 (1969).
Nayler, W.G., Price, J.M., Swann, J.B., McInnes, L, Race, D., Lowe, T.E.: Effect of the hypotensive drug St 155 (Catapres) on the heart and peripheral circulation. J. Pharmacol, exp. Ther. 164, 45–59 (1968).
Nayler, W.G., Rosenbaum, M., McInnes, L, Lowe, T.E.: Effect on a new hypotensive drug, St 155, on the systemic circulation. Amer. Heart J. 72, 764–770 (1966).
Nayler, W.G., Stone, J.: An effect of St 155 (Clonidine), 2-(2, 6-dichlorophenylamino)-2-imidazoline hydrochloride, (Catapres®), on relationship between blood pressure and heart rate in dogs. Europ. J. Pharmacol. 10, 161–167 (1970).
Neuhaus, G.A., Humpert, U.: Die Beeinflussung der gesteigerten Magensaftsekretion unter intramuskulärer Gabe von 2-(2, 6-Dichlorophenylamino-)-2-Imidazolin-hydrochlorid. In: Heilmeyer, Holtmeier, Pfeiffer (Eds.): Hochdrucktherapie, S. 205–210. Stuttgart: Thieme 1968.
Neumayr, R.J., Hare, B.D., Franz, D.N.: Depression of spinal vasomotor pathways by L-dopa and by Clonidine. Fifth International Congress on Pharmacology; Abstracts of Volunteer Papers p. 167, (997) (1972).
Nolly, H.L., Reíd, I.A., Ganong, W.F.: Effects of adrenergic agents on renin release in vitro. Fed. Proc. 33, 253 (1974).
Oberdorf, A., Kroneberg, G.: Weitere Untersuchungen zum Wirkungsmechanismus von 2-(2, 6-Dimethylphenylamino) 4H-5–6-dihydro 1–3-thiazin (Bayer 1470) am isolierten Meerschweinchen nach Paton. Arch. Pharm, exp. Path. 260, 183 (1968).
Oberdorf, A., Kroneberg, G.: The relationship between oc and ß receptor function and the liberation and action of acetylcholine on the coaxially stimulated guinea pig ileum. Fourth Int. Congress of Pharmacology, Abstracts. 144–145 (1969).
Oberdorf, A., Kroneberg, G.: Alphaund Betα-sympathicomimetische Wirkungen am elektrisch gezreizten isolierten Meerschweinchenileum. Arch. Pharmakol. 267, 195–207 (1970).
Olsen, V.B.: Clonidine induced increase of renal prostaglandin activity and water diuresis in conscious dogs. Europ. J. Pharmacol. 36, 95–102 (1976).
Onesti, G., Schwartz, A.B., Kim, K.E., Par-Martinez, V., Schwartz, C: Antihypertensive effect of Clonidine. Circulât. Res. 28, Suppl. 2, 53–69 (1971).
Ottenjann, R.: Sekretion, Motilität und Schleimhautdurchblutung des Magens unter dem Einfluß von Dichlorophenylaminoimidazolin. In: Heilmeyer, Holtmeier, Pfeiffer (Eds.): Hochdrucktherapie, S. 202–205. Stuttgart: Thieme 1968.
Ozawa, H., Miyatjchi, T., Stjgawara, K.: Potentiating effect of lithium chloride on aggressive behaviour induced in mice by nialamide plus L-dopa and by Clonidine. Europ. J. Pharmacol. 34, 169–180 (1975).
Paalzow, G., Paalzow, L.: Clonidine antinociceptive activity: effects of drugs influencing central monoaminergic and cholinergic mechanisms in the rat. Arch. Pharmacol. 292, 119–126 (1976).
Paalzow, L.: Analgesia produced by Clonidine in mice and rats. J. Pharm. Pharmacol. 26, 361–363 (1974).
Pacha, W., Salzmann, R., Scholtysik, G.: Inhibitory effects of Clonidine and BS 100–141 on responses to sympathetic nerve stimulation in cats and rabbits. Brit. J. Pharmacol. 53, 513–516 (1975).
Palmer, G. C, Sulser, F., Robinson, G. A.: Effects of neurohumoral and adrenergic agents on cyclic AMP levels in various areas of the rat brain in vitro. Neuropharmacology 12, 327–337 (1973).
Pascatjd, X.B., Roger, A. R.: Is the gastric antisecretory property of Clonidine in rats of central origine ? Brit. J. Pharmacol. 58, 419–420 (1976).
Paton, W.D.M., Vizi, E.S.: The inhibitory action of noradrenaline and adrenaline on acetylcholine output by guinea pig ileum longitudinal muscle strip. Brit. J. Pharmacol. 35, 10–28 (1969).
Persson, T.: Drug induced changes in 3H catecholamine accumulation after 3H tyrosine. Acta Pharmacol. Toxicol. 28, 378 (1970).
Persson, T., Waldeck, B.: Further studies on the possible interaction between dopamine and noradrenaline containing neurons in the brain. Europ. J. Pharmacol. 11, 315–320 (1970).
Pettinger, W.A., Keeton, K.E., Campbell, W.B., Harper, D.C.: Evidence for a renal α-adrenoceptor inhibiting renin release. Circulation Res. 38, 338–346 (1976).
Philippu, A., Roensberg, W., Przuntek, H.: Pressor response to hypothalamic stimulation as influenced by drugs affecting adrenergic receptors. Arch. Pharmacol. 277 Suppl., R55 (1973a).
Philipptj, A., Roensbergj, W., Przuntek, H.: Effects of adrenergic drugs on pressor responses to hypothalamic stimulation. Arch. Pharmacol. 278, 273–286 (1973 b).
Rand, M. J., Rush, M., Wilson, J.: Some observations on the inhibition of salivation by St 155 [2-(2, 6-dichlorophenylamino)-2-imidazoline hydrochloride, Catapres. Catapresan]. Europ. J. Pharmacol. 5, 168–172 (1969).
Rand, M.J., Wilson, J.: Mechanism of the pressor and depressor actions of St 155 [2-(2, 6-dichlorophenylamino-2-imidazoline hydrochloride, Catapres®]. Europ. J. Pharmacol. 3, 27–33 (1968).
Razak, A., Fusiwara, M., Ueki, S.: Automutilation induced by Clonidine in mice. Europ. J. Pharmacol. 30, 356–359 (1975).
Rehbinder, R.: The metabolism of Clonidine (Catapres, St 155). In: Conolly, M.E. (Ed.): Catapres in Hypertension, pp. 227–233. London: Butterworths 1970.
Rehbinder, D., Deckers, W.: Biochemische Untersuchungen zur Resorption, Verteilung und Ausscheidung des 2-(2, 6-Dichlorophenylamino)-2-Imidazolin-hydrochlorids bei der Ratte. Arzneimittel-Forsch. 16, 1052–1053 (1966).
Rehbinder, D., Deckers, W.: Stoffwechseleffekte des Catapresan®. Arch. Pharmakol. exp. Path. 261, 162–175 (1968).
Rehbinder, D., Deckers, W.: Untersuchungen zur Pharmakokinetik und am Metabolismus des 2-(2, 6-Dichlorophenylamino)-2-Imidazolin-hydrochlorid (St 155). Arzneimittel-Forsch. 19, 169–176 (1969).
Reid, I.A., Mac Donald, D.M., Ganong, W.F.: Suppression of renin secretion by Clonidine. Fed. Proc. 32, 765 (1973).
Reid, I.A., MacDonald, D.M., Pachnis, B., Ganong, W.F.: Studies concerning the mechanism of suppression of renin secretion by Clonidine. J. Pharmacol, exp. Therap. 192, 713–721 (1975).
Reíd, I. A., Pachnis, B., Ganong, W.F.: Mechanism of suppression of renin secretion by Clonidine. Fed. Proc. 33, 543 (1974).
Reíd, J.L., Briant, R.H., Dollery, C.T.: Desmethylimipramine and the hypotensive action of Clonidine in the rabbit. Life Sci. 12, 459–467 (1973).
Reíd, J.-L., Dollery, C.T.: Central noradrenergic neurons and the hypotensive actions of Clonidine. Fifth International Congress on Pharmacology. Abstracts of Volunteer Papers, p. 190 (1135) (1972).
Reíd, J. L., Lewis, P.L., Myers, M.G.: Role of central dopaminergic mechanisms on piribedil and Clonidine induced hypothermia in the rat. Neuropharmacology 14, 215–220 (1975).
Reubi, F.C, Vorburger, C, Butikofer, E.: A comparison of the short-term and long-term haemodynamic effects of antihypertensive drug therapy. In: Conolly, M.E. (Ed.): Catapres in Hypertension, pp. 113–125. London: Butterworths 1970.
Robson, R.D., Antonaccio, M.J.: Effects of Clonidine on responses to cardiac nerve stimulation as a function of impulse frequency and stimulus duration in vagotomized dogs. Europ. J. Pharmacol. 29, 182–186 (1974).
Robson, R.D., Kaplan, H.R.: A reflex cholinergic involvement of St 155 [2-(2, 6-dichloro-phenylamino)-2-imidazoline hydrochloride]. Pharmacologist 10, 157 (1968).
Robson, R.D., Kaplan, H.R.: An involvement of St 155 [2-(2, 6-dichlorophenylamino)-2-imidazoline hydrochloride, [Catapres®] in cholinergic mechanims. Europ. J. Pharmacol. 5, 328–337 (1969).
Robson, R.D., Kaplan, H. R., Laforce, J.: An analysis of the bradycardic effect of St 155 [2-(2, 6-dichlorophenylamino-2-imidazoline hydrochloride]. Fed. Proc. 28, 738 (1969a).
Robson, R.D., Kaplan, H.R., Laforce, S.: An investigation into the bradycardic effects of St 155 [2-(2, 6-dichlorophenylamino)-2-imidazoline HCl] in the anesthetized dog. J. Pharmacol, exp. Ther. 169, 120–131 (1969b).
Rochette, L., Bralet, J.: Effects of Clonidine on the synthesis of cerebral dopamine. Biochem. Pharmacol. 24, 303–305 (1975).
Rochette, L., Bralet, A.M., Bralet, J.: Influence de la Clonidine sur la synthèse et la libération de la noradrenaline dans différentes structures cérébrales du rat. J. Pharmacol. (Paris) 5, 209–220 (1974).
Rosenthal, J., Hoefke, W., Wolff, H.P.: Die Wirkung von 2-(2, 6-Dichlorophenylamino)-2-Imidazolin HCl auf Blutdruck und Plasmareninaktivität bei Ratten. Pflügers Arch. 312, R85–R86 (1969).
Ruch-Monachon, M.A., Jalfre, M., Haefely, W.: Drugs and PGO waves in the lateral geniculate body of the curarised cat. III. PGO waves and brain catecholamines. Arch. int. Pharmacol. Therap. 219, 287–307 (1976).
Saameli, K., Scholtysik, G., Waite, R.: Pharmacology of BS 100–141, a centrally acting antihypertensive drug. Clin. exp. Pharmac. Physiol., suppl. 2, 207–212 (1975).
Safar, M.E., Weiss, Y.A., Levenson, J.A., London, G.M., Milliez, P.L.: Antihypertensive effect of Clonidine and salt depletion in severe hypertension. Clinical and hemodynamic study. Europ. J. clin. Pharmacol. 5, 203–209 (1973).
Salt, J. L.: Inhibition of uptake2 in the isolated rat heart by steroids, Clonidine and methoxy-lated phenylethylamines. Europ. J. Pharmacol. 20, 329–340 (1972).
Sato, A., Schmidt, R.F.: Spinal and supraspinal components of the reflex discharges into lumbar and thoracic white rami. J. Physiol. (Lond.) 212, 839–850 (1971).
Sattin, A., Rall, T. W., Zanella, J.: Regulation of cyclic adenosine 3, 5’ monophosphate levels in guineα-pig cerebral cortex by interaction of α-adrenergic and adenosine receptor activity. J. Pharmacol, exp. Therap. 192, 22–32 (1975).
Sattler, R. W., Van Zwieten, P. A.: Acute hypotensive action of 2-(2, 6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155) after infusion into the cat’s vertebral artery. Europ. J. Pharmacol. 2, 9–13 (1967).
Scheja, H.W., Sturm, A. Jr.: Klinische Untersuchungen zum Wirkungsmechanismus der 2- (2, 6-Dichlorophenylamino)-2-Imidazolin HCl (Catapresan). Verh. dtsch. Ges. inn. Med. 74, 559–562 (1968).
Schmitt, H.: Reduction of central sympathetic tone by two new drugs. Central action of 2-(2, 6’-dichlorophenylamino)-2-imidazoline and reflex action of (pyrimidyl-2”-(l-methylene-dioxy-3’-4’-benzyl-4-piperazine). In: Bertelli, A. (Ed.): Circulatory drugs, pp. 153–154. Amsterdam: North Holland Publ. Com. 1969.
Schmitt, H.: Centrally mediated decrease in sympathetic tone induced by 2-(2, 6-dichloro-phenylamino)-2-imidazoline (St 155, Catapres). In: Conolly, M.E. (Ed.): Catapres in Hypertension, pp. 23–41. London: Butterworths 1970.
Schmitt, H.: On some unexplained effects of Clonidine. In: Milliez, P., Safar, M. (Eds.): Recent Advances in Hypertension, Vol. 2, pp. 63–72. Reims: Société Aliéna 1975.
Schmitt, H., Delbarre, B., Autret, A.-M.: Antagonism of the action of Clonidine on EEG. J. Pharmacol. (Paris) 2, 242 (1971a).
Schmitt, H., Fénard, S.: Interaction de la Clonidine (St 155) avec l’atropine, la mécamylamine et la bivagotomie. J. Pharmacol. (Paris) 1, 424–425 (1970a).
Schmitt, H., Fénard, S.: Influence de l’atropine, des ganglioplégiques et de la bivagotomie sur les effects hémodynamiques de la Clonidine. J. Pharmacol. (Paris) 1, 359–368 (1970b).
Schmitt, H., Fénard, S.: Effects des alcaloïdes de l’ergot de seigle sur les centres vasomoteurs et leur inhibition par la Clonidine. C. R. Soc. Biol. (Paris) 164, 1006–1009 (1970c).
Schmitt, H., Fénard, S.: Effects des substances sympathomimétiques sur les centres vaso-moteurs. Arch. int. Pharmacodyn. Thérap. 190, 229–240 (1971).
Schmitt, H., Fénard, S., Schmitt, Hélène: Influence d’agents ß-bloquants sur les effects inhibiteurs exercés par la Clonidine sur les centres vasomoteurs. J. Pharmacol. (Paris) 2, 369–372 (1971b).
Schmitt, H., Fournadjiev, G., Schmitt, Hélène: Central and peripheral effects of 2-(2, 6-dichlorophenylamino)4H 5–6 dihydro 1–3 thiazine (Bayer 1470) on sympathetic system. Europ. J. Pharmacol. 10, 230–238 (1970).
Schmitt, H., LeDottarec, J.-C, Pétillot, N.: Antinociceptive effects of some α-sympathomimetic agents. Neuropharmacology 13, 289–294 (1974a).
Schmitt, H., LeDouarec, J.-C, Pétillot, N.: Antagonism of the antinociceptive action of xylazine, an α-sympathomimetic agent by adrenoceptor and cholinoceptor blocking agents. Neuropharmacology 13, 295–303 (1974b).
Schmitt, H., Schmitt, Hélène: Localization of the hypotensive effect of 2-(2, 6-dichlorophenyl-amino)-2-imidazoline hydrochloride (St 155, Catapresan). Europ. J. Pharmacol. 6, 8–12 (1969a).
Schmitt, H., Schmitt, Hélène: α-sympathomimetic drugs with centrally mediated hypotensive effect. Fourth International Congress on Pharmacology. Abstracts 315–316 (1969b).
Schmitt, H., Schmitt, Hélène: Interactions between 2-(2, 6-dichlorophenylamino)-2-imid-azoline hydrochloride (St 155, Catapresan®) and α-adrenergic blocking drugs. Europ. J. Pharmacol. 9, 7–13 (1970).
Schmitt, H., Schmitt, Hélène, Boissier, J. -R., Giudicelli, J. -F.: Centrally mediated decrease in sympathetic tone induced by 2(2, 6-dichlorophenylammo)-2-imidazoline (St 155, Catapresan®). Europ. J. Pharmacol. 2, 147–148 (1967).
Schmitt, H., Schmitt, Hélène, Boissier, J.-R., Giudicelli, J.-F., Fichelle, J.: Cardiovascular effects of 2-(2, 6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155). II. Central sympathetic structures. Europ. J. Pharmacol. 2, 340–346 (1968).
Schmitt, H., Schmitt, Hélène, Fénard, S.: Influence of some α-adrenergic blocking drugs on the inhibitory effect of Clonidine on vasomotor centres. J. Pharmacol. (Paris) 2, 192 (1971 c).
Schmitt, H., Schmitt, Hélène, Fénard, S.: Evidence for an α-sympathomimetic component in the effects of Catapresan on vasomotor centres: antagonism by piperoxan. Europ. J. Pharmacol. 14, 98–100 (1971d).
Schmitt, H., Schmitt, Hélène, Fénard, S.: Action de l’ésérine, de l’oxotrémorine et de la mécamylamine sur les centres sympathiques et interférence avec les effects inhibiteurs de la Clonidine. J. Pharmacol. (Paris) 3, 118–119 (1972a).
Schmitt, H., Schmitt, Hélène, Fénard, S.: Action de l’ésérine, de l’oxotrémorine et de la mécamylamine sur les centres sympathiques et interférence avec les effects inhibiteurs de la Clonidine. J. Pharmacol. (Paris) 3, 423–434 (1972b).
Schmitt,H., Schmitt, Hélène, Fénard, S.: Influence of some drugs interfering with catecholamines on splanchnic discharges and blood pressure in conscious dogs. Fifth International Congress on Pharmacology. Abstracts of Volunteer papers, p. 204 (1222)1 (1972e).
Schmitt, H., Schmitt, Hélène, Fénard, S.: Action of α-adrenergic blocking drugs on the sympathetic centres and their interactions with the central sympatho-inhibitory effect of Clonidine. Arzneimittel-Forsch. 23, 40–45 (1973a).
Schmitt, H., Schmitt, Hélène, Fénard, S.: Decrease in the sympatho-inhibitory action of Clonidine after destruction of the sympatho-inhibitory area. Experientia (Basel) 29, 1247–1249 (1973b).
Schmitt, H., Schmitt, Hélène, Fénard, S.: A technique for recording splanchnic discharges in unanaesthetized dogs. Neuropharmacology 13, 247–250 (1974c).
Schmitt, H., Tsoucaris-Kupfer, D., Pétillot, N.: Hypothermia induced in rats by Clonidine and related compounds: Inhibition by adrenergic blocking agents. J. Pharmacol. (Paris) 2, 241 (1971e).
Schneider, K.W.: Cardialhämodynamik im akuten Versuch, nach chronischer Behandlung und im Belastungstest mit St 155. In: Hellmeyer, Holtmeier, Pfeiffer(Eds.): Hochdrucktherapie, S. 78–83. Stuttgart: Thieme 1968.
Schneider, K.W., Gattenlöhner, W.: Hämodynamische Untersuchungen nach St 155 [2-(2, 6-Dichlorophenylamino-2-ImidazoIin-hydrochlorid] beim Menschen. Dtsch. med. Wschr. 91, 1533–1539 (1966).
Scholtysik, G.: Inhibition of effects of accelerator nerve stimulation in cats and rabbits by BS 100–41 and guanabenz. Naunyn-Schmiedebergs Arch. Pharmacol. 282, R86 (1974).
Scholtysik, G., Salzmann, R.: Interaction between antidepressant and centrally antihypertensive drugs. Arch. Pharmacol. 279, Suppl., R. 23 (1973).
Schümann, H.J., Endoh, M.: α-adrenoceptors in the ventricular myocardium: Clonidine, naphazoline and methoxamine as partial α-agonists exerting a competitive dualism in action to phenylephrine. Europ. J. Pharmacol. 36, 413–421 (1976).
Schümann, H. J., Werner, U.: Hemmung der Hormonfreisetzung aus dem Nebennierenmark durch BAY a 6781, eine antihypertensiv wirksame Substanz. Arch. Pharmakol. 268, 71–82 (1971).
Scriabine, A., Stavorski, J. M.: Effect of Clonidine on the electrically-induced contraction of the isolated guineα-pig ileum. Fed. Proc. 29, 149 (1970).
Scriabine, A., Stavorski, J. M.: Effect of Clonidine on cardiac acceleration in vagotomized dogs. Europ. J. Pharmacol. 24, 101–104 (1973).
Scriabine, A., Stavorski, J.M.: Effects of phentolamine, phenoxybenzamine and desipramine on Clonidine blockade induced of cardiac acceleration in the dog. Europ. J. Pharmacol. 42, 63–70 (1977).
Scriabine, A., Stavorsky, J., Wenger, H.C, Torchiana, M.L., Stone, C.A.: Cardiac slowing effects of Clonidine (St 155) in dogs. J. Pharmacol, exp. Ther. 171, 256–264 (1970).
Scriabine, A., Stone, C. A., Stavorski, J.M.: Studies on the mechanism of Stl55-induced cardiac slowing in dogs. Pharmacologist 10, 156 (1968).
Scriabine, A., Sweet, CS., Ludden, C.T., Stavorski, J.M.: Central vs peripheral cardiovascular effects of 2-(2, 6-diethyl-phenylamino)-2-imidazoline hydrochloride (St 91). Sixth International Congress of Pharmacology Abstracts p. 636 (n° 1549) (1975).
Seller, H., Illert, M.: The localization of the first synapse in the carotid sinus baroreceptor reflex pathway and its alteration by the afferent input. Pflügers Arch. 306, 1–19 (1969).
Senft, G., Sift, R., Losert, W., Schultz, G., Hoffmann, W.: Hemmung der Insulininkretion durch Alphα-Receptoren-stimulierende Substanzen. Arch. Pharm, exp. Path. 260, 309–323 (1968).
Shaw, J., Htjnyor, S.N., Kornerj, L.: The peripheral circulatory effects of Clonidine and their role in the production of arterial hypotension. Europ. J. Pharmacol. 14, 101–111 (1971a).
Shaw, J., Hunyor, S.N., Körner, P.I.: Sites of central nervous action of Clonidine on reflex autonomic function in the unanaesthetized rabbit. Europ. J. Pharmacol. 15, 66–78 (1971 b).
Sherman, G.P., Grega, G.J., Woods, R.J., Buckley, J.P.: Evidence for a central hypotensive mechanism of 2-(2, 6-diehlorophenylamino)-2-imidazoline (Catapresan, St 155). Europ. J. Pharmacol. 2, 326–328 (1968).
Shoulson, L, Chase, T.N.: Clonidine and the antiparkinsonian response to L-dopa. Neuropharmacology 15, 25–27 (1976).
Simon, P.s, Chermat, R., Boissier, J.R.: Comparaison des effects sédatifs de deux αsym-pathomimétiques antihypertenseurs: la Clonidine et la tiaménidine. Thérapie 30, 855–861 (1975).
Sinha, J.N., Atkinson, J.M., Schmitt, H.: Effects of Clonidine and L-dopa on spontaneous and evoked splanchnic nerve discharges. Europ. J. Pharmacol. 24, 113–119 (1973).
Sinha, J.N., Tangri, K.K., Bhargava, K.P., Schmitt, H.: Central sites of sympatho-inhibitory effects of Clonidine and L-dopa. In: Milliez, P., Safar, M. (Eds.): Recent Advances in Hypertension, Vol. 1, pp. 97–109. Société Aliéna 1975.
Sjaastad, O., Stensrudj, P.: 2-(2, 6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155 or Catapresan) as a prophylactic remedy against migraine. Acta neurol. scand. 47, 120–122 (1971).
Skinhøj, E.: Die zerebrale hämodynamische Wirkung eines Imidazolin-Derivates mit blutdrucksenkender Wirkung. In: Heilmeyer, Holtmeier, Pfeiffer(Eds.): Hochdrucktherapie. Stuttgart: Thieme (1968).
Skolnick, P., Daly, J.W.: Stimulation of adenosine 3,’5’ monophosphate formation by alpha and beta adrenergic agonists in rat cerebral cortical slices: effects of Clonidine. Molec. Pharmacol. 11, 545–561 (1975).
Skolnick, P., Daly, J. W.: Interaction of Clonidine with pre and postsynaptic adrenergic receptors of rat brain: Effects on cyclic AMP generating systems. Europ. J. Pharmacol. 39, 11–21 (1976a).
Skolnick, P., Daly, J. W., Freedman, R., Hoffer, J.: Interelationship between catechol-amine-stimulated formation of adenosine 3, 5’ monophosphate in cerebellar slices and inhibitory effects on cerebellar Purkinje cells: antagonism by neuroleptic compounds. J. Pharmacol, exp. Therap. 197, 280–292 (1976b).
Sleight, P., West, M., Körner, P., Oliver, J., Chalmers, J., Robinson, J.: The action of Clonidine on the baroreflex control of heart rate in conscious animal and man and on single aortic baroreceptor discharge in the rabbit. Arch, inter. Pharmacod. Thérap. 214, 4–11 (1975).
Starke, K., Altmann, K.P.: Inhibition of adrenergic neurotransmission by Clonidine: an action on prejunctional α-receptors. Neuropharmacology 12, 339–347 (1973).
Starke, K., Montel, H.: Involvement of α-receptors in Clonidine induced inhibition of transmitter release from central monoamine neurones. Neuropharmacology 12, 1073–1080 (1973a).
Starke, K., Montel, H.: Alphareceptor-mediated modulation of transmitter release from central noradrenergic neurones. Naunyn-Schmiedeberg’s Arch. Pharmacol. 279, 53–60 (1973a).
Starke, K., Montel, H.: Influence of drugs with affinity for α-adrenoceptors on noradrenaline release by potassium, tyramine and dimethylphenylpiperazinium. Europ. J. Pharmacol. 27, 273–280 (1974).
Starke, K., Montel, H., Endo, T., Taube, H. D.: Pharmacological consequences of the presynaptic control of noradrenaline release. In: Milliez, P., Safar, M. (Eds.): Recent Advances in Hypertension, Vol. 2, pp. 75–84. Reims: Société Aliéna 1975.
Starke, K., Montel, H., Gayk, W., Merker, R.: Comparison of the effects of Clonidine on pre and postsynaptic adrenoceptors in the rabbit pulmonary artery. Naunyn-Schmiedeberg’s Arch. Pharmacol. 285, 133–150 (1974).
Starke, K., Schümann, A. J.: Zur peripheren sympathikushemmenden Wirkung des Clonidins. Experientia (Basel) 27, 70–71 (1971).
Starke, K., Wagner, J., Schümann, H.J.: Characterization of the peripheral antiadrenergic effect of Clonidine. Arch. Pharmakol. 270, Suppl. I, R1361 (1971).
Starke, K., Wagner, J., Schümann, H.J.: Adrenergic neuron blockade by Clonidine: comparison with guanethidine and local anesthetics. Arch. int. Pharmacod. Thérap. 195, 291–308 (1972).
Stauch, M.: Einfluß von Dichlorophenylaminoimidazolin (Catapres) auf die alveolare Ventilation und die Kurzschlußdurchblutung der Lunge. Klin. Wschr. 46, 505–507 (1968 a).
Stauch, M.: Die Wirkung von 2-(2, 6-Dichlorophenylamino)-2-Imidazolin HCl auf die arterielle Sauerstoffspannung und den Blutdruck in Ruhe und bei Belastung. Arzneimittel-Forsch. 18, 597–600 (1968b).
Stenberg, J., Holmberg, S., Naets, E., Varnauskas, E.: The hemodynamic effects of Catapresan. Central circulation at rest. Circulation at rest and during exercise. In: Heilmeyer, Holtmeier, Pfeiffer (Eds.): Hochdrucktherapie, pp. 68–75. Stuttgart: Thieme 1968.
Stjärne, L.: Mechanisms of catecholamine secretion. In: Usdin, E., Snyder, S.H. (Eds.): Frontiers in Catecholamine Research, pp. 491–496. New York-Toronto-Oxford-Sydney-Braunschweig: Pergamon Press 1973.
Struyker-Boudier, H. A. J.: Catecholamines receptors in nervous tissue. The release of neuronal catecholamine and receptors in the mode of action of dopaminergic and antihypertensive drugs. Nijmegen: Stiching Studentenpren 1975.
Struyker-Boudier, H.A. J., VanRossum, J.M.: Clonidine induced cardiovascular effects following stereotaxic application in the hypothalamus of rats. J. Pharm. Pharmacol. 24, 410–411 (1972).
Struyker-Boudier, H., Smeets, G., Brauwer, G., van Rossum, J.: Central and peripheral alpha adrenergic activity of imidazoline dérivâtes. Life Sci. 15, 887–899 (1974).
Sturm, A. Jr., Scheja, H.W.: Zur Wirkung des Catapresans auf den Blutdruck und die Ausscheidung des Hauptkatecholaminmetaboliten. In: Heilmeyer, Holtmeier, Pfeiffer(Eds.): Hochdrucktherapie, S. 99–104. Stuttgart: Thieme 1968.
Svensson, Th., Bunney, B.S., Aghajanian, G.K.: Inhibition of both noradrenergic and serotoninergic neurons in brain by the adrenergic agonist Clonidine. Brain Res. 92, 291–306 (1975).
Tanz, R.D.: On the mechanism of Catapresan induced hypotension and bradycardia. Pharmacologist 11, 270 (1969).
Tauberger, C, Kuhn, P., Brus, M.: Untersuchungen der zentralen sympathicusdämpfenden Wirkungen von Reserpin, Methyldopa und Clonidin. Arch. Pharmakol. 266, 464–465 (1970).
Toda, N., Fukuda, N., Shimamoto, K.: The mode of hypotensive action of 2-(2, 6-dichlor-ophenylamino)-2-imidazoline in the rabbit. Jap. J. Pharmacol. 19, 199–210 (1969).
Tran Quang Loc, Delbarre, B., Tsoucaris-Kupfer, D., Schmitt, H.: Antagonisme des effects de la Clonidine sur l’électrocorticogramme du lapin et du chat par des substances adrénolytiques a. J. Pharmacol. (Paris) 4, 415 (1973).
Tran Quang Loc, Tsoucaris-Kupfer, D., Bogaievsky, Y., Bogaievsky, D., Delbarre, B., Schmitt, H.: Antagonisme de l’action sédative de la Clonidine par quelques a adrénolytiques: étude électrocorticographique et comportementale chez le lapin et le chat. J. Pharmacol. (Paris) 5, 51–62 (1974).
Trolin, G.: Effect of pentobarbitone and decerebration on the Clonidine induced circulatory changes. Europ. J. Pharmacol. 34, 1–7 (1976).
Tseng, L.F., Loh, K.H., Wei, E.T.: Effects of Clonidine on morphine withdrawal signs in the rat. Europ. J. Pharmacol. 30, 93–99 (1975).
Tsotjcaris-Kupfer, D., Delbarre, B., Schmitt, H.: Actions antagonistes du pimozide et du pipéroxane sur les récepteurs dopaminergiquçs et noradrénergiques du système nerveux central. J. Pharmacol. (Paris) 4, 408–409 (1973).
Tsoucaris-Kupfer, D., Schmitt, H.: Action hypothermisante de substances α-sympathomi- métiques: Antagonisme avec quelques adrénolytiques et cholinolytiques. C. R. Acad. Sci. (Paris) 274, 607–610 (1972a).
Tsoucaris-Kupfer, D., ScHmitt, H.: Hypothermic effect of α-sympathomimetic agents and their antagonism by adrenergic and cholinergic blocking agents. Neuropharmacology 11, 625–635 (1972b).
Üvnas, B.: Central cardiovascular control. Handbook of Physiology, Neurophysiology Vol. 2, pp. 1131–1162, 1960.
Van Spanning, H.W., Van Zwieten, P.A.: The interference of tricyclic antidepressants with the central hypotensive effect of Clonidine. Europ. J. Pharmacol. 24, 402–404 (1973).
Van Zwieten, P.A.: Centrally induced hypotension by 2-(2, 6-dichlorophenyl)-5, 6-dihydroimidazo(2, l-b)thiazole fumarate (compound 44.594/15). Pharmacology 13, 352–353 (1975a).
VanZwieten, P.A.: Interaction between centrally acting hypotensive drugs and tricyclic antidepressants. Arch. int. Pharmacod. Thérap. 214, 12–30 (1975b).
Vorburger, G., Butikoferd, E., Reubi, F.: Die akute Wirkung von St 155 auf die cardiale und renale Hämodynamik. In: Heilmeyer, Holtmeier, Pfeiffer (Eds.): Hochdrucktherapie, S. 86–93.Stuttgart: Thieme 1968.
Vorburger, G., Butikofer, E., Weiss, S.: Die akute Wirkung von Catapresan, einem neuen Hypotensiven, auf die cardiale und renale Hämodynamik. Thirty-fifth Annual Meeting of the Schweizerische Gesellschaft für Kardiologie, p. 69–71 (1967a).
Vorburger, C., Butikofer, E., Weiss, S., Diacon, C.: Die akute Wirkung von St 155, einem neuen Hypotensiven auf kardiale und renale Hämodynamik. Helv. med. Acta 34, Suppl. 47, 133–134 (1967b).
Wahl, P.: Über die Wirkung von Catapresan auf den intravenösen Glucosetoleranztest. In: Heilmeyer, Holtmeier, Pfeiffer(Eds.): Hochdrucktherapie, S. 150–151. Stuttgart: Thieme 1968.
Waite, R.: Inhibition of sympathetic nerve activity resulting from central alpha adrenoceptor stimulation. In: Milliez, P., Safar, M. (Eds.): Recent Advances in Hypertension, pp. 27–36. Reims: Société Aliéna 1975.
Walland, A.: Blutdruck und Herzfrequenz der Ratte nach wiederholter Behandlung mit 2- (2, 6-Dichlorophenylamino)-2-imidazolin. Arzneimittel-Forsch. 18, 833–836 (1968).
Walland, A., Kobinger, W.: On the problem of tolerance of 2-(2, 6-dichlorophenylamino)-2- imidazoline. Arzneimittel-Forsch. 21, 61–65 (1971).
Walland, A., Kobinger, W.: Investigations upon the vagal regulation of the heart rate in conscious dogs. Arch. Pharmacol. 277, Suppl. R87 (1973).
Walland, A., Kobinger, W., Csongrady, A.: Action of Clonidine on baroreceptor reflexes in conscious dogs. Europ. J. Pharmacol. 26, 184–190 (1974).
Walz, A., VanZwieten, P.A.: The influence of 2-(2, 6-dichlorophenylamino)-2-imidazoline hydrochloride (Clonidine) and some related compounds on gastric secretion in the anesthetized rat. Europ. J. Pharmacol. 10, 369–377 (1970).
Warot, D.: Clonidine et contrôle noradrenergique des activités spinales réflexes. Thèse de médecine, Paris 1976.
Washizu, Y.: Stl55 on excitation-contraction in guinea pig-atrium. Arch. int. Pharmacod. Thérap. 188, 356–363 (1970).
Washizu, Y.: Some effects of Clonidine, procaine and tetrodotoxin on crayfish sensory neuron. Europ. J. Pharmacol. 14, 384–388 (1971).
Washizu, Y.: Differential effects of Clonidine on guineα-pig atrial and papillary muscles. Arch, int. Pharmacod. Thérap. 196, 184–191 (1972).
Weise, J., Stoetzer, H., Knappen, P., Walland, A.: The effect of Clonidine on the pupil diameter and the retina in rats, assessed in relation to the intensity of light. Arzneimittel-Forsch. 21, 821–825 (1971).
Wendt, F., Caspers, L: Körpertemperatur und Schweißsekretion bei körperlicher Belastung unter dem Einfluß von 2-(2, 6-Dichlorophenylamino)-2-Imidazolinhydrochlorid. In: Heilmeyer, Holtmeier, Pfeiffer(Eds.): Hochdrucktherapie, S. 197–201. Stuttgart: Thieme 1968.
Wermtjth, C.G., Schwartz, J., Leclerc, G., Garnier, J. P., Rouot, B.: Conformation de la Clonidine et hypothèses sur son interaction avec un récepteur a adrénergique. Chim. Thérap. 1, 115–116 (1973).
Werner, U., Starke, K., Schümann, H.J.: Wirkungen von Clonidin (St 155) und BAY a 6781 auf das isolierte Kaninchenherz. Arch. Pharmakol. 266, 474–475 (1970).
Werner, U., Starke, K., Schümann, H.J.: Actions of Clonidine and 2-(2-methyl-6-ethyl-cyclohexylamino)-2-oxazoline on postganglionic autonomic nerves. Arch. int. Pharmα- codyn. 195, 282–290 (1972).
Wilkinson, M.: Clonidine for migraine. Lancet 1969 II, 430.
Willis, L.R., Williamson, H.E.: The effect of Catapres on renal blood flow. Clin. Res. 17, 559 (1969).
Winchester, J., Kennedy, A.C.: Iatrogenic Raynaud’s Phenomenon. Brit. med. J. 1971 III, 113.
Woodhouse, B.L., Ram, N., Garvey, H.L.: Influence of St 155 (Catapres) upon efferent autonomic nerve activity. Fed. Proc. 31, 563 (Abstr.) (1972).
Zaïmis, E.: On the pharmacology of Catapres (St 155). In: Conolly, M.E. (Ed.): Catapres in hypertension, pp. 9–22. London: Butterworths 1970.
Zaïmis, E., Hanington, E.: A possible pharmacological approach to migraine. Lancet 1969 II, (9) 298–300.
Zimmermann, W., Michel, D., Seraphin, P. H.: Zur Wirkung von Catapres auf den kleinen Kreislauf. In: Heilmeyer, Holtmeier, Pfeiffer (Eds.): Hochdrucktherapie, S. 97–104. Stuttgart: Thieme 1968.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1977 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Schmitt, H. (1977). The Pharmacology of Clonidine and Related Products. In: Gross, F. (eds) Antihypertensive Agents. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 39. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66309-3_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-66309-3_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-66311-6
Online ISBN: 978-3-642-66309-3
eBook Packages: Springer Book Archive